论文部分内容阅读
目的探讨原发性肝癌(PLC)合并门脉癌栓(PVTT)的手术方法及价值。方法对18例PLC合并PVTT的患者行肝切除+门静脉癌栓清除术,术后予以辅助化疗。结果癌栓全部取出,无手术死亡,术后半年、1年、3年的生存率分别为100%、61.1%和11.1%。结论选择性地对PLC合并PVTT的患者行肝切除+门静脉癌栓清除术,可为后续治疗打下基础,提高疗效,并延长病人生存期。
Objective To investigate the surgical methods and the value of primary hepatocellular carcinoma (PLC) combined with portal vein tumor thrombus (PVTT). Methods 18 patients with PLC combined with PVTT underwent hepatectomy + portal vein tumor thrombectomy, after adjuvant chemotherapy. Results The tumor suppository was completely removed without any surgical death. The survival rates at six months, one year and three years after operation were 100%, 61.1% and 11.1%, respectively. Conclusion The selective hepatectomy + portal vein tumor thrombus removal in patients with PLC combined PVTT can lay a foundation for follow-up treatment, improve the curative effect and prolong the survival of patients.